World Pharma News

Eli Lilly and Company

LillyLilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.

Eli Lilly and Company RSS Channel

Display # 
Title Published Date
Lilly Diabetes launches new Disney book for families affected by type 1 diabetes 24 September 2015
Results from the largest known cholesterol survey conducted in the U.S. 05 November 2012
Boehringer Ingelheim and Lilly introduce the My Well Planner lifestyle improvement program 13 September 2012
Lilly Diabetes launches mobile application for whose who support people with type 1 diabetes 04 September 2012
Lilly reports second-quarter 2012 results 25 July 2012
Lilly expands strategic partnership with Chinese manufacturer Novast 12 June 2012
Lilly Introduces Global 'Innovation Starts Here' Initiative to Foster Innovation and Quality Science 04 March 2012
Lilly releases its most comprehensive corporate responsibility report 14 February 2012
Fifth Lilly Oncology on Canvas Art Competition invites all touched by cancer 09 February 2012
Most couples prefer spontaneity in the bedroom 11 December 2011
Understand Barriers to Progression of Insulin Treatment 01 December 2011
Lilly Provides Additional Funding to Infectious Disease Research Institute to Identify New Tuberculosis Therapies 24 November 2011
Lilly CEO Says Appropriate Assessment of Both Benefits and Risks Critical in Regulatory Process 02 November 2011
Lilly Reports Third-Quarter 2011 Results 21 October 2011
New Study Shows CialisĀ® Significantly Improved Study Endpoints 12 October 2011
Lilly Launches Open Innovation Drug Discovery Platform 29 September 2011
Lilly Invests $30 Million in Partnership to Address Non-Communicable Diseases 15 September 2011
Linagliptin Receives Approval in Europe for the Treatment of Type 2 Diabetes 26 August 2011
Lilly Announces Review of Data on Long-Term Raloxifene Treatment 10 August 2011
Lilly Global Giving Puts Power of Philanthropy in Employees' Hands 27 July 2011

Ā© World Pharma News 2006 - 2015

Top Desktop version